Understanding Merck KGaA's Upcoming Dividend Payout and Financial Health
Merck KGaA (MKKGY, Financial) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Merck KGaA's dividend performance and assess its sustainability.
What Does Merck KGaA Do?
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
A Glimpse at Merck KGaA's Dividend History
Merck KGaA has maintained a consistent dividend payment record since 2010. Dividends are currently distributed on a yearly basis. Merck KGaA has increased its dividend each year since 2010. The stock is thus listed as a dividend achiever, an honor that is given to companies that have increased their dividend each year for at least the past 14 years. Below is a chart showing annual Dividends Per Share for tracking historical trends.
Breaking Down Merck KGaA's Dividend Yield and Growth
As of today, Merck KGaA currently has a 12-month trailing dividend yield of 1.51% and a 12-month forward dividend yield of 1.47%. This suggests an expectation of decreased dividend payments over the next 12 months. Merck KGaA's dividend yield of 1.51% is near a 10-year high and outperforms 42.8% of global competitors in the Drug Manufacturers industry, suggesting that the company's dividend yield stands out as an attractive proposition for income investors.
Over the past three years, Merck KGaA's annual dividend growth rate was 19.20%. Extended to a five-year horizon, this rate decreased to 12.40% per year. And over the past decade, Merck KGaA's annual dividends per share growth rate stands at 8.40%.
Based on Merck KGaA's dividend yield and five-year growth rate, the 5-year yield on cost of Merck KGaA stock as of today is approximately 2.71%.
The Sustainability Question: Payout Ratio and Profitability
To assess the sustainability of the dividend, one needs to evaluate the company's payout ratio. The dividend payout ratio provides insights into the portion of earnings the company distributes as dividends. A lower ratio suggests that the company retains a significant part of its earnings, thereby ensuring the availability of funds for future growth and unexpected downturns. As of 2023-12-31, Merck KGaA's dividend payout ratio is 0.34.
Merck KGaA's profitability rank, offers an understanding of the company's earnings prowess relative to its peers. GuruFocus ranks Merck KGaA's profitability 9 out of 10 as of 2023-12-31, suggesting good profitability prospects. The company has reported positive net income for each year over the past decade, further solidifying its high profitability.
Growth Metrics: The Future Outlook
To ensure the sustainability of dividends, a company must have robust growth metrics. Merck KGaA's growth rank of 9 out of 10 suggests that the company's growth trajectory is good relative to its competitors.
Revenue is the lifeblood of any company, and Merck KGaA's revenue per share, combined with the 3-year revenue growth rate, indicates a strong revenue model. Merck KGaA's revenue has increased by approximately 6.20% per year on average, a rate that underperforms approximately 50.54% of global competitors.
The company's 3-year EPS growth rate showcases its capability to grow its earnings, a critical component for sustaining dividends in the long run. During the past three years, Merck KGaA's earnings increased by approximately 15.80% per year on average, a rate that underperforms approximately 43.1% of global competitors.
Lastly, the company's 5-year EBITDA growth rate of 25.70%, which underperforms approximately 23.28% of global competitors.
Next Steps
In conclusion, Merck KGaA's consistent dividend payments and growth rate, combined with a reasonable payout ratio and strong profitability, paint a promising picture for income-focused investors. The company's growth metrics, while mixed in comparison to global competitors, still indicate a solid foundation for future dividend sustainability. Investors considering Merck KGaA for its dividend prospects should also weigh these growth indicators to assess the potential for ongoing dividend increases. As the market continues to evolve, will Merck KGaA maintain its dividend achiever status and continue to reward shareholders? This is a key question for investors to ponder as they evaluate the company's long-term income-generating potential.
GuruFocus Premium users can screen for high-dividend yield stocks using the High Dividend Yield Screener.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
